Recent Finacing
Recent Raise
Confluence Pharmaceuticals (Carmel) is reformulating acamprosate licensed from Indiana University to treat Fragile X and autism, holding US and EU orphan designations and preparing Phase 1 FDA trials.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor